Table of Contents Table of Contents
Previous Page  S144 S290 Next Page
Information
Show Menu
Previous Page S144 S290 Next Page
Page Background

Results:

Significant improvements were achieved by SCGE in grip and

knee extension strength, functional reach, tandem stand, unipedal

stand, timed up and go, 360

o

turn, Berg balance test, fall efficacy

scale, gait for short physical performance battery, short-geriatric

depression scale, timed 10m walk test, 5 chair stand time and

30seconds chair stand (p

<

.05). However, no meaningful improvement

was observed in appendicular skeletal muscle mass index, physical

activity, cross sectional areas of rectus femoris and multifidus.

Conclusions:

Frail older people were able to gain significant muscle

strength, functions and even improved mood without meaningful in-

crease of muscle mass through 24 weeks of SCGE. These results

demonstrate that SCGE is beneficial for physical and mental functions of

old people although it is not hard enough to gain additional musclemass.

Level of Evidence:

Level II

Poster 6:

Relationship Between Berg Balance Scale and Short

Physical Performance Battery to Evaluate Fall Risk in

Older Adults

Ana L. Villagrana Rodriguez (Hospital Civil de Guadalajara Fray

Anton, Tala, Jalisco, Mexico), Tonatiuh Avila Garcia, MD,

Ana C. Gutierrez, MD, Daniel Pacheco Covarrubias, MD, Jose´ de Jesus

Gonzalez Jaime, MD

Disclosures:

Ana Villagrana Rodriguez: I Have No Relevant Financial

Relationships To Disclose

Objective:

To analyze the relationship between scores of Berg Bal-

ance Scale (BBS) and Short Physical Performance Battery (SPPB) to

evaluate fall risk in an older adults sample.

Design:

Cross- sectional study.

Setting:

Department of Physical Medicine and Rehabilitation at a

public tertiary hospital.

Participants:

Fifty subjects, aged 65 to 98 years, male and female;

severe cardiopulmonary diseases, impaired ability to walk, cognitive

deficits, acute musculoskeletal injuries, blindness and deafness were

exclusion criteria.

Interventions:

Not applicable.

Main Outcome Measures:

We measured balance using BBS and SPPB;

relationship between scores was analyzed by Spearman’s (rho)

coefficient.

Results:

Mean age was 75.28 7.31 years, 64% were female and 36%

male. We found a positive, moderate (rho

¼

0.69) and statistically

significant (p

<

.01) correlation between BBS and SPPB scores.

Conclusions:

SPPB and BBS are useful tools to evaluate fall risk in

older adults. In spite of SPPB simplicity there is not enough evidence to

support its use instead of BBS, complementary studies are needed to

determine the definitive relationship between these instruments.

Level of Evidence:

Level III

Poster 7:

Comparative Effectiveness of Microprocessor

Controlled and Carbon Fiber Energy Storing and

Returning Prosthetic Feet in Persons with Unilateral

Transtibial Amputation: Pilot Study

Brian Kaluf (Ability Prosthetics and Orthotics, Inc., Exton, PA, USA)

Disclosures:

Brian Kaluf: Research Grants - Freedom Innovations, LLC

Objective:

This pilot study compared perceived balance and mobility,

functional capabilities, socket comfort and ramp ambulation between

energy storing and returning (ESAR) and microprocessor controlled

prosthetic ankle (MPA) components in patients with unilateral trans-

tibial amputation.

Design:

Randomized AB cross-over design.

Setting:

Outpatient prosthetic clinic.

Participants:

4 unilateral transtibial amputees with average age (54),

mass (97 kg), K-level (3.75).

Interventions:

Patient’s habitual prosthetic ankle, control ESAR

(Pacifica LP) and MPA (Kinnex, Freedom Innovations, Irvine, CA). An-

kles were assembled to participants’ current socket in a random order.

Testing was performed initial after assembly and after a 4-week ac-

commodation period.

Main Outcome Measures:

Prosthesis Evaluation Questionnaire

e

Mobility Subscale (PEQ-MS), Prosthetic Limb User Survey of Mobility

(PLUS-M), Orthotic and Prosthetic User Survey Satisfaction with Device

(OPUS), Activities Specific Balance Confidence (ABC) and Socket Comfort

Score (SCS); Amputee Mobility Predictor with Prosthesis (AMPPRO), L Test

of Functional Mobility (L Test), 5 times Sit-to-Stand (5x STS), 6 min Timed-

Walk-Test (6min TWT), Physiological Cost Index (PCI); Hill Assessment

Index (HAI), prosthesis side ankle and knee angles at mid-stance of gait

during ramp ascent and descent (6 ft long ramp with 15 deg slope)

measured with 2D video motion analysis (PnO Data Live, iPad Air 2).

Results:

Effect of prosthetic ankle-foot was found to be statistically

significant (

a

¼

0.05) in five of the measures. HAI on ramp descent

showed improved function with Kinnex, and a significant difference

between Kinnex and habitual Ankle. Angle measurements showed a

trend of the Kinnex providing more accommodation at the ankle during

slope ascent and a more stable knee position at mid-stance in slope

descent. Several differences in knee and ankle angle between ankle-

foot configurations reached statistical significance.

Conclusions:

The study showed statistically significant benefits with

the Kinnex on ramp ascent and descent, while other measures showed

positive trends of improved balance, mobility, and socket comfort with

the Kinnex.

Level of Evidence:

Level II

Poster 8:

Investigation of an Unobtrusive Carpal Tunnel Tissue

Manipulation Device for the Treatment of Carpal

Tunnel Syndrome: A Pilot Clinical Trial

Pauline T. Luong, MEng (Pressure Profile Systems, Los Angeles, CA,

United States), Frank J. King, MD, Zong-Ming Li, PhD,

Matthew A. Dickason, MBA, Matthew C. Diamond, MD PhD, Jae Son,

PhD

Disclosures:

Pauline Luong: Employment (full or part-time) - Pressure

Profile Systems

Objective:

To investigate the feasibility, safety, and efficacy of a

carpal tunnel tissue manipulation device (CTMD) to treat carpal tunnel

syndrome (CTS) in patients with mild to severe CTS when worn for 8-10

hours daily for 4 weeks.

Design:

Single-group, open-label, prospective, pilot clinical trial.

Setting:

Daily home use with clinic visits.

Participants:

11 subjects with mild to severe CTS: 7 treated for uni-

lateral CTS, 4 treated for bilateral CTS; 7 female, 4 male; ages 28-65.

Interventions:

The CTMD is a novel unobtrusive orthotic device

applied to the volar aspect of the wrist and designed to relieve pres-

sure off the median nerve. Each subject was asked to wear the

CTMD(s) on the affected wrist(s) for 8-10 hours daily and complete a

Usage Diary daily for 4 weeks. Subjects completed a Boston Carpal

Tunnel Questionnaire (BTCQ) at 0, 2, 4, and 12 weeks post-baseline.

Main Outcome Measures:

Symptom Severity Scale (SSS) of the BCTQ:

1 to 5 rating of CTS symptom severity (1 being less severe, 5 being most

severe).

Results:

For all subjects, SSS scores improved from baseline scores on

average by 0.59 (SD 0.68, p

<

.05) at 4 weeks post-baseline. SSS

continued to improve 8 weeks post-treatment, improving by an

average of 0.79 (SD 0.74, p

<

.01) compared to baseline. Unilateral

subjects improved more than bilateral subjects (mean 1.2, SD 0.5; vs.

mean 0.09, SD 0.41) at 8-weeks post-treatment. Daily wear compli-

ance was very high, with only 2 patients self-reporting not wearing the

device once (though there were occasional missed diary entries).

Conclusions:

Patients with unilateral CTS who wore the CTMD daily

for at least 4 weeks experienced an improvement in severity of CTS

S144

Abstracts / PM R 9 (2017) S131-S290